Loss of SFXN1 mitigates lipotoxicity and predicts poor outcome in non-viral hepatocellular carcinoma
Kohei Yagi(Tokyo Medical and Dental University), Shinji Tanaka(Tokyo Institute of Technology), Megumi Hatano(Tokyo Medical and Dental University), Daisuke Asano(Tokyo Medical and Dental University), Yoshiya Ishikawa(Tokyo Medical and Dental University), Hiroaki Ono(Saitama Medical University), Shuichi Watanabe(Kanazawa University), Shu Shimada(Tokyo Medical and Dental University), Hiroki Ueda(Tokyo University of Science), Keiichi Akahoshi(Tokyo Medical and Dental University), Minoru Tanabe(Tokyo Institute of Technology), Yoshimitsu Akiyama(Tokyo Medical and Dental University)
Cited by 9
Related Papers
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780
A novel difficulty scoring system for laparoscopic liver resection
|Journal of Hepato-Biliary-Pancreatic Sciences|2014|560
Comprehensive molecular and immunological characterization of hepatocellular carcinoma
|EBioMedicine|2018|277
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267